PROF

Profound Medical (PROF)

Profound Medical Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PROF

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/15	06 : 23	Edgar (US Regulatory)	Form F-X - Appointment of Agent for Service of Process and Undertaking	NASDAQ:PROF	Profound Medical Corporation
2024/06/15	06 : 01	Edgar (US Regulatory)	Form F-10 - Registration Statement for Securities of certain Canadian Issuers.	NASDAQ:PROF	Profound Medical Corporation
2024/06/15	05 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PROF	Profound Medical Corporation
2024/06/04	05 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PROF	Profound Medical Corporation
2024/05/16	06 : 00	GlobeNewswire Inc.	Profound Medical Annual General Meeting of Shareholders Voting Results	NASDAQ:PROF	Profound Medical Corporation
2024/05/16	05 : 12	PR Newswire (Canada)	PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS	NASDAQ:PROF	Profound Medical Corporation
2024/05/14	22 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PROF	Profound Medical Corporation
2024/05/14	20 : 30	GlobeNewswire Inc.	Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan	NASDAQ:PROF	Profound Medical Corporation
2024/05/10	05 : 15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PROF	Profound Medical Corporation
2024/05/10	05 : 05	GlobeNewswire Inc.	Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance	NASDAQ:PROF	Profound Medical Corporation
2024/05/07	05 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PROF	Profound Medical Corporation
2024/05/07	05 : 15	GlobeNewswire Inc.	Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum	NASDAQ:PROF	Profound Medical Corporation
2024/04/23	05 : 15	GlobeNewswire Inc.	Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow	NASDAQ:PROF	Profound Medical Corporation
2024/04/09	20 : 45	GlobeNewswire Inc.	Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference	NASDAQ:PROF	Profound Medical Corporation
2024/03/08	06 : 05	GlobeNewswire Inc.	Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:PROF	Profound Medical Corporation
2024/03/05	06 : 30	GlobeNewswire Inc.	Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference	NASDAQ:PROF	Profound Medical Corporation
2024/02/27	21 : 45	GlobeNewswire Inc.	Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure	NASDAQ:PROF	Profound Medical Corporation
2024/02/16	06 : 30	GlobeNewswire Inc.	Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow	NASDAQ:PROF	Profound Medical Corporation
2024/01/17	06 : 30	GlobeNewswire Inc.	Profound Medical Announces Non-Brokered Private Placement	NASDAQ:PROF	Profound Medical Corporation
2024/01/04	06 : 15	GlobeNewswire Inc.	Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues	NASDAQ:PROF	Profound Medical Corporation
2023/12/28	12 : 40	GlobeNewswire Inc.	Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares	NASDAQ:PROF	Profound Medical Corporation
2023/12/28	06 : 15	GlobeNewswire Inc.	Profound Medical Announces Proposed Public Offering of Common Shares	NASDAQ:PROF	Profound Medical Corporation
2023/11/08	21 : 45	GlobeNewswire Inc.	Profound Medical to Participate in the Stifel 2023 Healthcare Conference	NASDAQ:PROF	Profound Medical Corporation
2023/11/03	21 : 00	GlobeNewswire Inc.	Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting	NASDAQ:PROF	Profound Medical Corporation
2023/11/03	05 : 05	GlobeNewswire Inc.	Profound Medical Announces Third Quarter 2023 Financial Results	NASDAQ:PROF	Profound Medical Corporation
2023/10/20	05 : 30	GlobeNewswire Inc.	Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow	NASDAQ:PROF	Profound Medical Corporation
2023/10/11	05 : 30	GlobeNewswire Inc.	Profound Medical 2023 Virtual Analyst & Investor Day Agenda	NASDAQ:PROF	Profound Medical Corporation
2023/09/26	05 : 05	GlobeNewswire Inc.	Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost	NASDAQ:PROF	Profound Medical Corporation
2023/09/21	21 : 00	GlobeNewswire Inc.	Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13	NASDAQ:PROF	Profound Medical Corporation
2023/09/20	05 : 45	GlobeNewswire Inc.	Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference	NASDAQ:PROF	Profound Medical Corporation